PURPOSE: Penile squamous cell carcinoma (SCC) is a rare entity, with few published series on outcomes.
We evaluated the stage distributions and outcomes for surgery and radiation therapy in a U.S. population database.
METHODS AND MATERIALS: Subjects with SCC of the penis were identified using the National Cancer Institute Surveillance, Epidemiology and End Results (SEER) Program database between 1988 and 2006. Descriptive statistics were performed, and cause-specific survival (CSS) was estimated using Kaplan-Meier analysis. Comparisons of treatment modalities were analyzed using multivariate Cox regression. Subjects were staged using American Joint Committee on Cancer, sixth edition, criteria.
RESULTS: There were 2458 subjects identified. The median age was 66.8 years (range, 17-102 years). Grade 2 disease was present in 94.5% of cases. T1, T2, T3, T4, and Tx disease was present in 64.8%, 17.1%, 9.5%, 2.1%, and 6.5% of cases, respectively. N0, N1, N2, N3, and Nx disease was noted in 61.6%, 6.9%, 4.0%, 3.7%, and 23.8% of cases, respectively. M1 disease was noted in 2.5% of subjects. Individuals of white ethnicity accounted for 85.1% of cases. Lymphadenectomy was performed in 16.7% of cases. The CSS for all patients at 5 and 10 years was 80.8% and 78.6%. By multivariable analysis grades 2 and 3 disease, T3 stage, and positive lymph nodes were adverse prognostic factors for CSS.
CONCLUSION: SCC of the penis often presents as early-stage T1, N0, M0, grade 1, or grade 2 disease. The majority of patients identified were treated with surgery, and only a small fraction of patients received radiation therapy alone or as adjuvant therapy.
Written by:
Burt LM, Shrieve DC, Tward JD. Are you the author?
Radiation Oncology Department, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Reference: Int J Radiat Oncol Biol Phys. 2013 Oct 9. pii: S0360-3016(13)03015-0.
doi: 10.1016/j.ijrobp.2013.08.013
PubMed Abstract
PMID: 24119832
UroToday.com Penile and Urethral Cancers Section
